AceView: Gene:DHX30, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
BX449007	fetal liver, Liver	.a	-8 to 958	21 to 978		tiling clone,		958/978 (97 %)	20 diff (98.0 %id)
BX449006	fetal liver, Liver	.a	2719 to 3703	983 to 1		tiling clone,		983/988 (99 %)	8 diff (99.2 %id)
NM_138615.2		.b	1 to 4086	1 to 4086	exact	RefSeq, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	4086/4086 (100 %)	0 diff (100 %id)
DB454748	testis	.b	20 to 495	1 to 476		tiling clone,		476/476 (100 %)	0 diff (100 %id)
BC028405	Brain, hippocampus	.b	227 to 4083	8 to 3863	T159A P175Q L265V Q518K S600C ...	available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	3856/3856 (100 %)	8 diff (99.8 %id)
DA277537	corpus callosum	.b	231 to 795	2 to 566		capped		565/565 (100 %)	0 diff (100 %id)
DB268156	uterus	.b	231 to 728	2 to 499		capped		498/498 (100 %)	0 diff (100 %id)
AL555884	placenta	.b	240 to 1174	1 to 933				933/933 (100 %)	8 diff (99.2 %id)
BI910096	leukocyte	.b	246 to 955	1 to 713				713/713 (100 %)	15 diff (97.9 %id)
BC020126	Lymph, lymphoma	.b	253 to 4083	1 to 3831	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	3831/3831 (100 %)	0 diff (100 %id)
CN390142	embryonic stem cells, cell lines H1, H7, andH9	.b	254 to 946	1 to 695				695/695 (100 %)	5 diff (99.3 %id)
BF794552	lymph, lymphoma, cell line	.b	254 to 1072	1 to 819				819/1132 (72 %)	35 diff (97.0 %id)
CN390143	embryonic stem cells, DMSO-treated H9 cellline	.b	255 to 443	1 to 189				189/189 (100 %)	0 diff (100 %id)
CD358712	testis	.b	255 to 977	1 to 731				731/915 (79 %)	23 diff (97.5 %id)
BU594473	mixed (pool of 40 RNAs)	.b	271 to 1012	1 to 744				744/848 (87 %)	20 diff (97.7 %id)
AB020697	brain	.b	284 to 4083	1 to 3800	exact	available from KIAA,		3800/3800 (100 %)	0 diff (100 %id)
BM904372	lymph, lymphoma, cell line	.b	291 to 1182	1 to 911				910/1006 (90 %)	25 diff (97.6 %id)
BU193557	leiomyosarcoma, uterus	.b	294 to 1029	1 to 738				738/943 (78 %)	15 diff (98.5 %id)
BM476976	leiomyosarcoma, uterus	.b	299 to 1206	1 to 918				918/1115 (82 %)	35 diff (96.9 %id)
AI815600	brain, frontal lobe	.b	361 to 710	1 to 350				350/350 (100 %)	0 diff (100 %id)
AI928932	brain, frontal lobe	.b	361 to 779	1 to 418				418/418 (100 %)	1 diff (99.8 %id)
DA467707	cord Blood	.b	534 to 1107	2 to 575		capped		574/574 (100 %)	0 diff (100 %id)
BX282025	lymph, lymphoma, cell line	.b	578 to 1062	1 to 485				485/485 (100 %)	0 diff (100 %id)
BM478224	lymph, lymphoma, cell line	.b	578 to 1518	1 to 945				945/1037 (91 %)	18 diff (98.3 %id)
BM477540	lymph, lymphoma, cell line	.b	627 to 1408	1 to 788				788/1068 (73 %)	27 diff (97.5 %id)
BF981852	duodenal adenocarcinoma, cell line, small intestine	.b	663 to 1415	1 to 759				759/972 (78 %)	23 diff (97.7 %id)
BG911254	anaplastic oligodendroglioma with 1p/19qloss, brain	.b	676 to 1363	1 to 687				687/687 (100 %)	9 diff (98.7 %id)
CN390159	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.b	738 to 1403	1 to 666				666/666 (100 %)	2 diff (99.7 %id)
BG748455	eye, normal pigmented retinal epithelium	.b	814 to 1554	1 to 736				736/736 (100 %)	7 diff (99.1 %id)
BG106308	lymph, lymphoma, cell line	.b	900 to 1604	1 to 709		AAA		709/1009 (70 %)	11 diff (99.0 %id)
BF314883	brain, neuroblastoma	.b	1024 to 1752	1 to 726				726/870 (83 %)	23 diff (97.4 %id)
BI196226	brain, neuroblastoma	.b	1024 to 1640	1 to 617				617/617 (100 %)	0 diff (100 %id)
BQ707490	Spleen	.b	1043 to 1933	1 to 892				892/894 (99 %)	11 diff (98.8 %id)
BM800978	melanotic melanoma, skin	.b	1092 to 1799	1 to 708				708/1036 (68 %)	9 diff (99.2 %id)
CO402182	Chondrosarcoma Lung Metastasis cell lines, lung	.b	1112 to 1780	1 to 665				665/844 (78 %)	11 diff (98.7 %id)
CO246559	Chondrosarcoma Lung Metastasis cell lines, lung	.b	1149 to 1893	44 to 787				744/795 (93 %)	15 diff (98.2 %id)
BQ071124	brain, neuroblastoma, cell line	.b	1216 to 2102	1 to 899				899/1008 (89 %)	20 diff (98.1 %id)
BF312690	brain, neuroblastoma	.b	1226 to 1969	1 to 735				735/920 (79 %)	14 diff (98.5 %id)
BE313325	brain, neuroblastoma	.b	1281 to 2029	1 to 752				752/876 (85 %)	16 diff (98.2 %id)
BG753442	eye, normal pigmented retinal epithelium	.b	1292 to 2086	1 to 792				792/889 (89 %)	23 diff (97.5 %id)
TI_59386539		.b	1440 to 2246	61 to 871				811/812 (99 %)	11 diff (98.7 %id)
BM008822	adenocarcinoma, Pancreas	.b	1441 to 2246	1 to 810				810/811 (99 %)	11 diff (98.7 %id)
TI_154197383		.b	1473 to 2369	110 to 1003				894/979 (91 %)	26 diff (97.4 %id)
BF237602	leiomyosarcoma cell line, uterus	.b	1648 to 2432	1 to 783				783/792 (98 %)	11 diff (98.7 %id)
BU190572	melanotic melanoma, cell line, skin	.b	1688 to 2500	22 to 841				818/872 (93 %)	15 diff (98.3 %id)
BQ676354	melanotic melanoma, cell line, skin	.b	1688 to 2530	13 to 860				848/941 (90 %)	19 diff (98.0 %id)
BQ681788	melanotic melanoma, cell line, skin	.b	1688 to 2532	22 to 871				850/948 (89 %)	23 diff (97.6 %id)
BQ678124	melanotic melanoma, cell line, skin	.b	1688 to 2632	22 to 971				950/972 (97 %)	25 diff (97.5 %id)
BQ877506	melanotic melanoma, cell line, skin	.b	1692 to 2482	1 to 796				796/869 (91 %)	6 diff (99.4 %id)
BU179205	melanotic melanoma, cell line, skin	.b	1692 to 2596	1 to 908				908/914 (99 %)	11 diff (98.8 %id)
BU161098	melanotic melanoma, cell line, skin	.b	1692 to 2540	1 to 850				850/932 (91 %)	10 diff (99.0 %id)
BQ682063	melanotic melanoma, cell line, skin	.b	1692 to 2412	1 to 722				722/958 (75 %)	15 diff (98.5 %id)
BQ684531	melanotic melanoma, cell line, skin	.b	1692 to 2535	1 to 846				846/925 (91 %)	19 diff (98.0 %id)
BQ684193	melanotic melanoma, cell line, skin	.b	1692 to 2491	1 to 803				803/932 (86 %)	14 diff (98.5 %id)
BU190883	melanotic melanoma, cell line, skin	.b	1692 to 2436	1 to 745				745/858 (86 %)	6 diff (99.4 %id)
BQ679373	melanotic melanoma, cell line, skin	.b	1692 to 2613	1 to 925				925/925 (100 %)	17 diff (98.2 %id)
BX441027	brain, fetal brain	.b	1753 to 2715	1 to 959				959/959 (100 %)	5 diff (99.5 %id)
BE740533	adenocarcinoma cell line, ovary	.b	1779 to 2564	1 to 778				778/987 (78 %)	17 diff (98.3 %id)
CA487784		.b	1809 to 2715	1 to 918				918/1006 (91 %)	14 diff (98.7 %id)
BM710474	eye, RPE and Choroid	.b	1822 to 2312	1 to 491				491/491 (100 %)	0 diff (100 %id)
DR763115	embryonic stem	.b	1872 to 2529	1 to 658				658/658 (100 %)	1 diff (99.9 %id)
CR985154	T-Lymphocytes	.b	1895 to 2451	1 to 557				557/559 (99 %)	1 diff (99.9 %id)
CA454590		.b	1909 to 2713	1 to 812				812/897 (90 %)	8 diff (99.2 %id)
BQ052997	blood, natural killer cells, cell line	.b	1941 to 2633	1 to 700				700/1064 (65 %)	25 diff (97.7 %id)
BE384979	melanotic melanoma, skin	.b	1969 to 2615	1 to 646				646/649 (99 %)	2 diff (99.7 %id)
U69564	whole brain	.b	2028 to 4083	1 to 2054		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	2054/2054 (100 %)	6 diff (99.8 %id)
CR992145	T-Lymphocytes	.b	2092 to 2954	1 to 863				863/863 (100 %)	8 diff (99.1 %id)
BG765647	melanotic melanoma, high MDR (cell line), skin	.b	2168 to 2994	1 to 829				829/829 (100 %)	4 diff (99.6 %id)
CF272423	Brain glioblastoma	.b	2172 to 2957	1 to 791				789/870 (90 %)	5 diff (99.5 %id)
BE710163	head_neck	.b	2186 to 2416	231 to 1				231/231 (100 %)	0 diff (100 %id)
BX103993	whole brain	.b	2215 to 2748	1 to 534				534/534 (100 %)	0 diff (100 %id)
BU155002	melanotic melanoma, skin	.b	2220 to 2993	1 to 780				780/902 (86 %)	8 diff (99.2 %id)
BQ316378	colon	.b	2243 to 2864	1 to 622				622/622 (100 %)	0 diff (100 %id)
AL135247	melanoma (MeWo cell line)	.b	2271 to 2540	1 to 270				270/270 (100 %)	0 diff (100 %id)
BE740552	adenocarcinoma cell line, ovary	.b	2276 to 3128	1 to 841				841/978 (85 %)	17 diff (98.3 %id)
BQ935053	epidermoid carcinoma, cell line, lung	.b	2313 to 3248	1 to 944				942/945 (99 %)	17 diff (98.3 %id)
BQ922537	epidermoid carcinoma, cell line, lung	.b	2313 to 3195	1 to 894				894/937 (95 %)	17 diff (98.2 %id)
CV802680	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.b	2317 to 3045	1 to 715				717/827 (86 %)	14 diff (98.4 %id)
BG029791	breast, mammary adenocarcinoma, cell line	.b	2318 to 3010	1 to 693				693/1057 (65 %)	7 diff (99.4 %id)
F06591	brain, total brain	.b	2321 to 2690	1 to 369				369/369 (100 %)	1 diff (99.8 %id)
BU174270	melanotic melanoma, cell line, skin	.b	2362 to 3130	25 to 793				769/975 (78 %)	19 diff (98.1 %id)
BQ717098	sympathetic trunk	.b	2363 to 3176	1 to 827				827/834 (99 %)	18 diff (97.9 %id)
BU190535	melanotic melanoma, cell line, skin	.b	2370 to 3176	1 to 818				818/844 (96 %)	13 diff (98.5 %id)
BQ892619	melanotic melanoma, cell line, skin	.b	2370 to 3250	1 to 885				885/885 (100 %)	9 diff (99.0 %id)
BQ676644	melanotic melanoma, cell line, skin	.b	2370 to 3190	1 to 828				828/973 (85 %)	17 diff (98.3 %id)
BU185568	melanotic melanoma, cell line, skin	.b	2370 to 3195	1 to 831				831/949 (87 %)	15 diff (98.5 %id)
BQ683654	melanotic melanoma, cell line, skin	.b	2370 to 3112	1 to 742				742/926 (80 %)	15 diff (98.4 %id)
BQ681597	melanotic melanoma, cell line, skin	.b	2373 to 3206	19 to 855				837/920 (90 %)	30 diff (96.8 %id)
CA489592		.b	2415 to 3260	1 to 849				847/851 (99 %)	5 diff (99.5 %id)
BM917113	blood, natural killer cells, cell line	.b	2443 to 3355	1 to 921				921/1092 (84 %)	11 diff (99.0 %id)
BQ052874	blood, natural killer cells, cell line	.b	2443 to 3336	1 to 906				906/1051 (86 %)	27 diff (97.5 %id)
CD673957	eye, lens	.b	2458 to 2843	1 to 386			Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	386/386 (100 %)	0 diff (100 %id)
BG679886	skin, squamous cell carcinoma	.b	2483 to 3190	1 to 706				706/706 (100 %)	4 diff (99.5 %id)
BM786190	stomach	.b	2484 to 3075	1 to 592				592/592 (100 %)	0 diff (100 %id)
TI_1948135353		.b	2503 to 3195	129 to 824				696/1235 (56 %)	18 diff (98.6 %id)
TI_1948135354		.b	2503 to 3197	127 to 820				694/1270 (54 %)	17 diff (98.7 %id)
TI_1948135716		.b	2503 to 3166	132 to 802				671/1310 (51 %)	29 diff (97.8 %id)
TI_1948136066		.b	2503 to 3197	125 to 821				697/1255 (55 %)	23 diff (98.2 %id)
TI_1948136067		.b	2503 to 3190	129 to 817				689/1289 (53 %)	19 diff (98.6 %id)
TI_1948136418		.b	2503 to 3193	126 to 816				691/1217 (56 %)	10 diff (99.2 %id)
BC014237	Uterus, leiomyosarcoma	.b	2506 to 4083	1 to 1578		available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	1578/1578 (100 %)	1 diff (100.0 %id)
BI117168	lung, small cell carcinoma	.b	2514 to 3321	1 to 803				803/882 (91 %)	22 diff (97.6 %id)
BG387511	embryonal carcinoma, cell line, testis	.b	2521 to 3290	1 to 759				759/940 (80 %)	15 diff (98.5 %id)
CD514089	brain, Pituitary	.b	2583 to 3411	1 to 841				841/930 (90 %)	25 diff (97.4 %id)
BM802985	duodenal adenocarcinoma, cell line, small intestine	.b	2610 to 3352	1 to 749				749/1099 (68 %)	17 diff (98.5 %id)
BI256017	cervical carcinoma cell line, cervix	.b	2627 to 3298	1 to 672				672/672 (100 %)	1 diff (99.9 %id)
AW250316	lung, small cell carcinoma	.b	2639 to 3103	10 to 474			Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	465/474 (98 %)	7 diff (98.6 %id)
BE741712	adenocarcinoma cell line, ovary	.b	2640 to 3514	1 to 874				874/945 (92 %)	28 diff (97.1 %id)
BM708493	eye, RPE and Choroid	.b	2650 to 2952	1 to 301			Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	301/301 (100 %)	3 diff (99.1 %id)
BE906531	epithelioid carcinoma, Pancreas	.b	2658 to 3420	1 to 760				760/765 (99 %)	11 diff (98.6 %id)
BM700068	eye, lens	.b	2674 to 3254	1 to 581			Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	581/581 (100 %)	1 diff (99.9 %id)
BI117491	lung, small cell carcinoma	.b	2693 to 3486	1 to 786				786/797 (98 %)	13 diff (98.4 %id)
BM709299	eye, optic nerve	.b	2734 to 3073	1 to 340				340/340 (100 %)	0 diff (100 %id)
BQ053840	blood, natural killer cells, cell line	.b	2774 to 3592	1 to 825				825/956 (86 %)	8 diff (99.2 %id)
CN390141	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.b	2833 to 3278	1 to 446				446/446 (100 %)	0 diff (100 %id)
CX783646	human embryonic stem cells	.b	2837 to 3618	1 to 781				781/781 (100 %)	1 diff (99.9 %id)
BQ716979	sympathetic trunk	.b	2864 to 3709	1 to 859				859/861 (99 %)	24 diff (97.3 %id)
BQ069201	brain, neuroblastoma, cell line	.b	2866 to 3760	1 to 896				896/1018 (88 %)	9 diff (99.2 %id)
BM473514	melanotic melanoma, skin	.b	2884 to 3872	8 to 1004				997/1105 (90 %)	24 diff (97.9 %id)
CA489882		.b	2884 to 3752	26 to 899				874/925 (94 %)	17 diff (98.2 %id)
BQ943356	brain, neuroblastoma, cell line	.b	2914 to 3842	1 to 931				931/937 (99 %)	19 diff (98.0 %id)
BU171814	melanotic melanoma, skin	.b	2919 to 3753	16 to 861				846/861 (98 %)	23 diff (97.4 %id)
AA310536		.b	2935 to 3223	1 to 289				289/289 (100 %)	0 diff (100 %id)
TI_57177245		.b	2935 to 3742	26 to 831				806/831 (96 %)	14 diff (98.4 %id)
BI831017	brain, medulla	.b	2937 to 3742	1 to 805				805/805 (100 %)	9 diff (98.9 %id)
BE294282	muscle, rhabdomyosarcoma	.b	2977 to 3623	1 to 646				646/647 (99 %)	7 diff (99.0 %id)
BI092474	cervix	.b	3012 to 3734	1 to 723				723/724 (99 %)	3 diff (99.6 %id)
BQ644225	hepatocellular carcinoma, cell line, Liver	.b	3038 to 3760	12 to 735				724/873 (82 %)	18 diff (98.0 %id)
BQ647505	hepatocellular carcinoma, cell line, Liver	.b	3038 to 3998	9 to 974				966/974 (99 %)	20 diff (98.0 %id)
BQ647260	hepatocellular carcinoma, cell line, Liver	.b	3038 to 3874	8 to 845				838/881 (95 %)	16 diff (98.2 %id)
BQ650491	hepatocellular carcinoma, cell line, Liver	.b	3038 to 3874	9 to 853				845/914 (92 %)	16 diff (98.3 %id)
BQ649224	hepatocellular carcinoma, cell line, Liver	.b	3038 to 3874	8 to 850				843/943 (89 %)	29 diff (97.0 %id)
BQ651310	hepatocellular carcinoma, cell line, Liver	.b	3038 to 3874	8 to 849				842/996 (84 %)	21 diff (97.9 %id)
BQ653267	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3760	1 to 714				714/931 (76 %)	10 diff (99.0 %id)
BQ648635	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3713	1 to 665				665/956 (69 %)	25 diff (97.4 %id)
BQ649965	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3925	1 to 891				891/904 (98 %)	42 diff (95.4 %id)
BQ645225	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3872	1 to 837				837/858 (97 %)	20 diff (97.7 %id)
BQ645880	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3805	1 to 766				766/904 (84 %)	8 diff (99.2 %id)
BQ653936	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3952	1 to 914				914/915 (99 %)	31 diff (96.7 %id)
BQ646423	hepatocellular carcinoma, cell line, Liver	.b	3048 to 4000	1 to 955				955/956 (99 %)	15 diff (98.5 %id)
BQ876525	hepatocellular carcinoma, cell line, Liver	.b	3048 to 3869	1 to 825				825/861 (95 %)	8 diff (99.1 %id)
CD674466	eye, lens	.b	3070 to 3653	1 to 584			Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	584/584 (100 %)	0 diff (100 %id)
CD674616	eye, lens	.b	3070 to 3159	1 to 90				90/90 (100 %)	0 diff (100 %id)
AL578271	placenta	.b	3084 to 4049	960 to 1				960/960 (100 %)	14 diff (98.6 %id)
TI_154135335		.b	3084 to 4083	1074 to 89		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	988/1026 (96 %)	33 diff (96.8 %id)
CB159844	Liver	.b	3133 to 3737	1 to 605				605/605 (100 %)	0 diff (100 %id)
AW176593	colon	.b	3169 to 3427	259 to 1				259/259 (100 %)	0 diff (100 %id)
BU192945	eye, retinoblastoma	.b	3177 to 4029	1 to 867				867/889 (97 %)	35 diff (96.1 %id)
BI160809	epithelioid carcinoma cell line, Pancreas	.b	3201 to 3890	1 to 692				692/952 (72 %)	5 diff (99.5 %id)
TI_154135353		.b	3224 to 4083	929 to 77		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	853/984 (86 %)	17 diff (98.3 %id)
BX455037	brain, fetal brain	.b	3227 to 4071	869 to 9				861/894 (96 %)	26 diff (97.1 %id)
CD674326	eye, lens	.b	3246 to 3684	1 to 439				439/439 (100 %)	0 diff (100 %id)
CN390152	embryonic stem cells, cell lines H1, H7, andH9	.b	3286 to 4029	11 to 754				744/754 (98 %)	7 diff (99.1 %id)
BM707362	eye, eye anterior segment	.b	3309 to 3708	9 to 408		fully sequenced,	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	400/408 (98 %)	1 diff (99.8 %id)
BG764992	melanotic melanoma, high MDR (cell line), skin	.b	3334 to 4063	1 to 731				731/732 (99 %)	5 diff (99.4 %id)
BQ233869	epithelioid carcinoma, Pancreas	.b	3351 to 4083	756 to 22		AAA	Submitted on the opposite strand	735/875 (84 %)	7 diff (99.2 %id)
AI697628	carcinoid, lung	.b	3374 to 3819	446 to 1				446/446 (100 %)	0 diff (100 %id)
BF341878	brain, glioblastoma with EGFR amplification	.b	3409 to 4084	1 to 677		AAA		677/691 (97 %)	3 diff (99.6 %id)
TI_149285548		.b	3412 to 4083	756 to 85		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	672/672 (100 %)	1 diff (99.9 %id)
TI_154023099		.b	3423 to 4083	750 to 90		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	661/661 (100 %)	1 diff (99.9 %id)
BU608014	Human Lung Epithelial cells, lung	.b	3426 to 4083	676 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	658/658 (100 %)	0 diff (100 %id)
BM971467	lung	.b	3497 to 4083	605 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	587/587 (100 %)	0 diff (100 %id)
BU737869	eye, lens	.b	3497 to 4083	605 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	587/587 (100 %)	1 diff (99.9 %id)
CA439325	lung, Metastatic Chondrosarcoma	.b	3497 to 4083	605 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	587/587 (100 %)	0 diff (100 %id)
CD368247	Alveolar Macrophage, lung	.b	3505 to 4086	600 to 19		tiling clone, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	582/582 (100 %)	0 diff (100 %id)
CA426688	cell lines, Chondrosarcoma	.b	3506 to 4083	596 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	578/578 (100 %)	0 diff (100 %id)
AI815879	brain, frontal lobe	.b	3545 to 4084	548 to 9				540/548 (98 %)	0 diff (100 %id)
BE349448	malignant melanoma, metastatic to lymphnode, skin	.b	3549 to 4081	533 to 1				533/533 (100 %)	0 diff (100 %id)
BU732445	eye, optic nerve	.b	3550 to 4078	552 to 24		AAA		529/534 (99 %)	0 diff (100 %id)
CB217755	mandible, pooled	.b	3575 to 4083	1 to 509		fully sequenced, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	509/509 (100 %)	0 diff (100 %id)
AW071607	pooled germ cell tumors	.b	3592 to 4083	492 to 1				492/492 (100 %)	0 diff (100 %id)
AW006629	colon	.b	3593 to 4084	492 to 1				492/492 (100 %)	0 diff (100 %id)
AW029278	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.b	3593 to 4084	492 to 1				492/492 (100 %)	0 diff (100 %id)
DB527551	testis	.b	3616 to 4083	1 to 468			Submitted on the opposite strand	468/468 (100 %)	0 diff (100 %id)
CD673956	eye, lens	.b	3621 to 4079	476 to 18		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	459/459 (100 %)	1 diff (99.8 %id)
DB522729	testis	.b	3622 to 4077	1 to 456			Submitted on the opposite strand	456/456 (100 %)	0 diff (100 %id)
AW250994	lung, small cell carcinoma	.b	3625 to 4083	469 to 11		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	459/459 (100 %)	0 diff (100 %id)
BQ008273	Chondrosarcoma, Left Pelvis	.b	3626 to 4083	476 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	458/458 (100 %)	0 diff (100 %id)
CN390156	embryonic stem cells, DMSO-treated H9 cellline	.b	3638 to 4079	1 to 442				442/442 (100 %)	0 diff (100 %id)
AI929185	brain, frontal lobe	.b	3651 to 4084	442 to 9				434/442 (98 %)	0 diff (100 %id)
BQ188007	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.b	3676 to 4083	1 to 408		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	408/408 (100 %)	0 diff (100 %id)
BM673473	eye, eye anterior segment	.b	3678 to 4083	424 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	406/406 (100 %)	2 diff (99.6 %id)
CN390161	embryonic stem cells, DMSO-treated H9 cellline	.b	3683 to 3989	1 to 307				307/307 (100 %)	0 diff (100 %id)
BM671932	eye, RPE and Choroid	.b	3684 to 4078	418 to 24		AAA		395/400 (98 %)	3 diff (99.3 %id)
AJ710636	heart	.b	3699 to 4083	1 to 385		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	385/385 (100 %)	0 diff (100 %id)
BG331948	large cell carcinoma, lung	.b	3723 to 4083	1 to 361		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	361/361 (100 %)	0 diff (100 %id)
CB217754	mandible, pooled	.b	3727 to 4083	401 to 45		fully sequenced, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	357/357 (100 %)	0 diff (100 %id)
BG759170	B-cells, primary B-cells from tonsils (cell line)	.b	3739 to 4083	1 to 345		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	345/345 (100 %)	0 diff (100 %id)
CD674465	eye, lens	.b	3757 to 4082	353 to 28		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	326/330 (98 %)	3 diff (99.1 %id)
AI244327	Kidney	.b	3765 to 4084	320 to 1				320/320 (100 %)	0 diff (100 %id)
Z39572	brain, total brain	.b	3772 to 4083	311 to 1				311/311 (100 %)	1 diff (99.7 %id)
BU730799	eye, RPE and Choroid	.b	3803 to 4083	299 to 19		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	281/281 (100 %)	0 diff (100 %id)
AI648464	ovary, tumor, 5 pooled (see description)	.b	3834 to 4084	251 to 1				251/251 (100 %)	0 diff (100 %id)
DV459028	cochlea, ear	.b	3918 to 4035	118 to 1			Submitted on the opposite strand	118/118 (100 %)	0 diff (100 %id)
AA016091	eye, retina	.b	3957 to 4077	121 to 1			Submitted on the opposite strand	121/121 (100 %)	0 diff (100 %id)
AI344056	colon, colon tumor, RER+	.b	3993 to 4082	90 to 1				90/90 (100 %)	0 diff (100 %id)
NM_014966.3		.c	1 to 4115	1 to 4115	exact	RefSeq, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	4115/4115 (100 %)	0 diff (100 %id)
DB444698	testis	.c	153 to 575	1 to 423		tiling clone,		423/423 (100 %)	3 diff (99.3 %id)
DB453077	testis	.c	172 to 674	1 to 503				503/503 (100 %)	1 diff (99.9 %id)
AK291266		.c	226 to 4112	1 to 3887	I518T G742D			3887/3887 (100 %)	4 diff (99.9 %id)
DB462117	testis	.c	227 to 710	1 to 485				485/489 (99 %)	3 diff (99.4 %id)
DA757687		.c	227 to 780	2 to 556		capped		555/557 (99 %)	3 diff (99.5 %id)
DB445899	testis	.c	247 to 710	1 to 462				462/465 (99 %)	3 diff (99.4 %id)
DB458920	testis	.c	247 to 701	1 to 455				455/455 (100 %)	0 diff (100 %id)
BI832242	brain, medulla	.c	251 to 788	1 to 540				540/542 (99 %)	10 diff (98.2 %id)
TI_57176439		.c	251 to 788	1 to 540				540/542 (99 %)	10 diff (98.2 %id)
BC038417	Brain, adult medulla	.c	254 to 4112	1 to 3859	exact	available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	3859/3859 (100 %)	1 diff (100.0 %id)
BC015029	Uterus, leiomyosarcoma	.c	255 to 4112	1 to 3858	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	3858/3858 (100 %)	0 diff (100 %id)
BM146460	leukopheresis	.c	255 to 600	1 to 346				346/346 (100 %)	3 diff (99.2 %id)
DB463216	hippocampus	.c	275 to 623	1 to 348				348/348 (100 %)	12 diff (96.6 %id)
BE886425	leiomyosarcoma, uterus	.c	276 to 803	1 to 533				531/700 (75 %)	9 diff (98.8 %id)
CA391835	eye, RPE/choroid	.c	302 to 661	51 to 410				360/410 (87 %)	8 diff (98.1 %id)
DB459339	testis	.c	558 to 1039	1 to 482				482/482 (100 %)	0 diff (100 %id)
DB461673	testis	.c	558 to 1033	1 to 476				476/476 (100 %)	1 diff (99.8 %id)
DB452025	testis	.d	1 to 497	1 to 497		tiling clone,		497/497 (100 %)	1 diff (99.8 %id)
BG723223	testis	.d	16 to 629	1 to 616				616/706 (87 %)	23 diff (96.8 %id)
DB457282	testis	.d	31 to 499	1 to 469				469/469 (100 %)	0 diff (100 %id)
DA454883	tongue, tumor tissue	.d	41 to 601	2 to 562		tiling clone, capped		561/561 (100 %)	1 diff (99.9 %id)
DA874497	Prostate	.d	52 to 462	2 to 412		capped		411/411 (100 %)	0 diff (100 %id)
AI971425	pooled germ cell tumors	.d	100 to 638	538 to 1				538/538 (100 %)	16 diff (97.1 %id)
BI562729	testis	.d	545 to 1367	1 to 823		tiling clone,		821/936 (87 %)	52 diff (94.5 %id)
TI_44351232		.d	547 to 1367	136 to 956				819/1069 (76 %)	50 diff (95.4 %id)
DR000672	fetal brain	.d	602 to 1168	1 to 569				569/569 (100 %)	7 diff (98.8 %id)
BG717956	testis	.d	607 to 1330	1 to 722				722/723 (99 %)	11 diff (98.5 %id)
BM172229	testis	.d	607 to 1176	1 to 580				536/580 (92 %)	13 diff (97.8 %id)
BI562582	testis	.d	607 to 1292	1 to 683				683/683 (100 %)	7 diff (99.0 %id)
TI_44350998		.d	608 to 1292	133 to 814				682/814 (83 %)	10 diff (98.8 %id)
DB081626	testis	.d	611 to 1119	2 to 510		capped		509/509 (100 %)	2 diff (99.7 %id)
DA622441	Kidney	.d	613 to 1149	2 to 538		capped		537/537 (100 %)	2 diff (99.7 %id)
DA713842		.d	613 to 1160	2 to 549		capped		548/548 (100 %)	0 diff (100 %id)
DA692583		.d	617 to 1182	2 to 567		capped		566/566 (100 %)	1 diff (99.9 %id)
DB450707	testis	.d	618 to 1081	1 to 464				464/465 (99 %)	8 diff (98.3 %id)
BG717465	testis	.d	620 to 1389	9 to 777				769/798 (96 %)	36 diff (95.5 %id)
BI462964	testis	.d	622 to 1320	1 to 705				702/705 (99 %)	25 diff (96.5 %id)
BI463314	testis	.d	622 to 1320	1 to 701				701/701 (100 %)	14 diff (98.1 %id)
CN357999	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.d	624 to 1002	1 to 379				379/379 (100 %)	1 diff (99.8 %id)
CD109598	Human Placenta, placenta	.d	625 to 1300	28 to 708				681/755 (90 %)	11 diff (98.6 %id)
CF994324	Human Placenta, placenta	.d	625 to 1298	29 to 701				673/714 (94 %)	13 diff (98.2 %id)
BU553757	ovary, teratocarcinoma, cell line	.d	628 to 1287	33 to 697				665/1036 (64 %)	17 diff (98.4 %id)
DA239801	brain	.d	629 to 1162	2 to 535		capped		534/534 (100 %)	0 diff (100 %id)
BQ070878	brain, neuroblastoma, cell line	.d	629 to 1508	1 to 879		tiling clone,		879/1016 (86 %)	13 diff (98.8 %id)
CN357995	embryonic stem cells, cell lines H1, H7, andH9	.d	630 to 1087	1 to 459				459/459 (100 %)	7 diff (98.5 %id)
CN357997	embryonic stem cells, cell lines H1, H7, andH9	.d	630 to 1048	1 to 419				419/419 (100 %)	1 diff (99.8 %id)
BG335538	choriocarcinoma, placenta	.d	631 to 1294	1 to 662				662/663 (99 %)	10 diff (98.5 %id)
DA701200		.d	635 to 1087	2 to 454		capped		453/467 (97 %)	2 diff (99.6 %id)
DA306360	hippocampus	.d	637 to 1184	2 to 549		capped		548/548 (100 %)	0 diff (100 %id)
N26265	melanocyte	.d	640 to 1065	1 to 425			Submitted on the opposite strand	425/425 (100 %)	13 diff (97.0 %id)
AA015964	eye, retina	.d	640 to 1037	1 to 397			Submitted on the opposite strand	397/397 (100 %)	12 diff (97.0 %id)
AI097043	uterus	.d	640 to 1132	1 to 493			Submitted on the opposite strand	493/493 (100 %)	3 diff (99.4 %id)
AI568540	anaplastic oligodendroglioma, brain	.d	640 to 1156	1 to 517			Submitted on the opposite strand	517/518 (99 %)	2 diff (99.7 %id)
AW024763	Kidney	.d	640 to 1162	1 to 522			Submitted on the opposite strand	522/522 (100 %)	1 diff (99.9 %id)
AW207396		.d	641 to 1054	1 to 414			Submitted on the opposite strand	414/414 (100 %)	2 diff (99.6 %id)
BI545634	brain, hippocampus	.d	642 to 1367	1 to 715				715/718 (99 %)	27 diff (96.3 %id)
TI_44165714		.d	650 to 1367	150 to 856				707/859 (82 %)	26 diff (97.0 %id)
BM553968	brain, medulla	.d	653 to 1396	1 to 746				746/1039 (71 %)	26 diff (97.5 %id)
BF431634	Kidney	.d	658 to 1275	1 to 618			Submitted on the opposite strand	618/618 (100 %)	7 diff (98.9 %id)
CR987977	T-Lymphocytes	.d	660 to 1245	1 to 586				586/588 (99 %)	4 diff (99.4 %id)
BG424809	Kidney, renal cell adenocarcinoma	.d	671 to 1317	1 to 649				649/649 (100 %)	8 diff (98.8 %id)
CN357996	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.d	678 to 997	1 to 320				320/320 (100 %)	1 diff (99.7 %id)
CN357998	embryonic stem cells, cell lines H1, H7, andH9	.d	679 to 1041	1 to 363				363/363 (100 %)	0 diff (100 %id)
BP872318	embryonal kidney	.d	679 to 1256	1 to 581				581/581 (100 %)	7 diff (98.8 %id)
BE387209	melanotic melanoma, skin	.d	679 to 1281	57 to 679				618/685 (90 %)	45 diff (93.5 %id)
BF002879	Prostate	.d	690 to 952	12 to 278			Submitted on the opposite strand	267/278 (96 %)	6 diff (97.9 %id)
AA760791	germinal center B cell	.d	705 to 1066	1 to 362			Submitted on the opposite strand	362/362 (100 %)	9 diff (97.6 %id)
DB453665	testis	.d	732 to 1232	1 to 501				501/502 (99 %)	1 diff (99.9 %id)
CO245964	Chondrosarcoma Lung Metastasis cell lines, lung	.d	768 to 1389	1 to 620				620/812 (76 %)	14 diff (98.3 %id)
BF984839	duodenal adenocarcinoma, cell line, small intestine	.d	781 to 1484	1 to 702				702/777 (90 %)	18 diff (97.7 %id)
BU500183		.d	781 to 1656	12 to 892		tiling clone,		881/903 (97 %)	19 diff (97.9 %id)
BG661326	Islets of Langerhans, Pancreas	.e	1 to 591	1 to 591		tiling clone,		591/591 (100 %)	2 diff (99.7 %id)
BI199708	brain, neuroblastoma	.e	130 to 960	1 to 837				837/837 (100 %)	29 diff (96.6 %id)
BE260182	brain, neuroblastoma	.e	149 to 730	1 to 584		tiling clone,		584/587 (99 %)	6 diff (99.0 %id)
BE312303	brain, neuroblastoma	.e	149 to 682	1 to 534				534/534 (100 %)	0 diff (100 %id)
BF568110	epithelioid carcinoma cell line, Pancreas	.e	655 to 1453	1 to 828		tiling clone,		828/988 (83 %)	15 diff (98.5 %id)
BQ707019	Spleen	.f-u	1 to 833	10 to 850		tiling clone,		848/968 (87 %)	20 diff (98.0 %id)
TI_154195750		.f-u	309 to 1110	68 to 864				797/1019 (78 %)	48 diff (95.3 %id)
BG329088	eye, retinoblastoma	.f-u	310 to 1100	1 to 783				783/783 (100 %)	31 diff (96.1 %id)
BG472912	eye, retinoblastoma	.f-u	310 to 1054	1 to 760				760/760 (100 %)	29 diff (96.2 %id)
BG474185	eye, retinoblastoma	.f-u	310 to 784	1 to 476				476/476 (100 %)	4 diff (99.2 %id)
BE900626	choriocarcinoma, placenta	.f-u	316 to 972	14 to 662				649/961 (67 %)	19 diff (98.1 %id)
CT002226	T-Lymphocytes	.f-u	319 to 868	1 to 550				550/550 (100 %)	3 diff (99.5 %id)
BE251705	eye, retinoblastoma	.f-u	330 to 1033	1 to 702				702/756 (92 %)	8 diff (99.0 %id)
BG831146	epithelioid carcinoma cell line, Pancreas	.f-u	341 to 1105	1 to 766				766/766 (100 %)	5 diff (99.4 %id)
TI_154195732		.f-u	368 to 1139	22 to 788				767/1031 (74 %)	25 diff (97.6 %id)
BU196575	melanotic melanoma, cell line, skin	.f-u	482 to 1149	22 to 689		tiling clone,		668/848 (78 %)	2 diff (99.8 %id)
BQ680701	melanotic melanoma, cell line, skin	.f-u	486 to 1154	1 to 671		tiling clone,		671/916 (73 %)	10 diff (99.0 %id)
BQ682090	melanotic melanoma, cell line, skin	.f-u	486 to 780	1 to 295				295/295 (100 %)	0 diff (100 %id)
BQ680772	melanotic melanoma, cell line, skin	.f-u	486 to 1155	1 to 673				673/898 (74 %)	13 diff (98.6 %id)
AK096791	Prostate	.g	1 to 1957	1 to 1957	R198G	tiling clone, available from FLJ,		1957/1957 (100 %)	1 diff (100.0 %id)
DA875134	Prostate	.g	2 to 553	2 to 553		capped		552/552 (100 %)	0 diff (100 %id)
CD242427	brain, Pituitary	.g	661 to 1223	7 to 574		tiling clone,		568/967 (58 %)	9 diff (99.1 %id)
BM715079	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.g	956 to 1102	1 to 147			Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	147/147 (100 %)	1 diff (99.4 %id)
BF372128	prostate_tumor	.g	1123 to 1400	283 to 9				275/283 (97 %)	0 diff (100 %id)
BU739985	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.g	1341 to 1957	636 to 20		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	617/618 (99 %)	0 diff (100 %id)
DB330105	Prostate	.g	1422 to 1957	537 to 1				537/537 (100 %)	1 diff (99.9 %id)
AA808524	carcinoid, lung	.g	1465 to 1956	492 to 1				492/492 (100 %)	0 diff (100 %id)
BF435361	pooled	.g	1486 to 1962	477 to 1		tiling clone,		477/477 (100 %)	1 diff (99.8 %id)
AW593272	pooled	.g	1488 to 1959	472 to 1				472/472 (100 %)	3 diff (99.4 %id)
T06043		.g	1518 to 1828	312 to 1				312/312 (100 %)	2 diff (99.4 %id)
AW130650	poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus	.g	1527 to 1957	431 to 1				431/431 (100 %)	3 diff (99.4 %id)
BF435997	pooled	.g	1617 to 1962	348 to 3				346/348 (99 %)	0 diff (100 %id)
BM805408	brain, hippocampus	.h	1 to 902	24 to 929		tiling clone,		906/1081 (83 %)	19 diff (98.3 %id)
TI_57184184		.h	289 to 1061	33 to 823				724/829 (87 %)	42 diff (95.0 %id)
BI767944	pooled lung and spleen	.h	290 to 1061	1 to 790				723/796 (90 %)	39 diff (95.2 %id)
CR999350	T-Lymphocytes	.h	396 to 1110	1 to 717				717/720 (99 %)	3 diff (99.6 %id)
BG336302	choriocarcinoma, placenta	.h	437 to 1225	1 to 789	L170W R171A F172S I173S H174T ...	tiling clone,		789/1077 (73 %)	20 diff (98.2 %id)
CN390153	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.h	476 to 1169	1 to 695		tiling clone,		695/695 (100 %)	2 diff (99.8 %id)
BG473667	eye, retinoblastoma	.h	476 to 1206	1 to 731		tiling clone,		731/731 (100 %)	5 diff (99.4 %id)
CB154988	brain	.h	494 to 1134	1 to 641		tiling clone,		641/641 (100 %)	0 diff (100 %id)
BX281666	melanotic melanoma, skin	.h	594 to 1071	1 to 478				478/478 (100 %)	0 diff (100 %id)
CN390158	embryonic stem cells, cell lines H1, H7, andH9	.i	1 to 576	12 to 587		tiling clone,		576/587 (98 %)	6 diff (99.0 %id)
CN390157	embryonic stem cells, cell lines H1, H7, andH9	.i	173 to 579	1 to 407				407/407 (100 %)	4 diff (99.1 %id)
CN390162	embryonic stem cells, cell lines H1, H7, andH9	.i	197 to 843	9 to 656				648/656 (98 %)	7 diff (99.0 %id)
CN390149	embryonic stem cells, cell lines H1, H7, andH9	.i	214 to 826	1 to 613				613/613 (100 %)	0 diff (100 %id)
BP353036		.i	554 to 1147	1 to 594		tiling clone,		594/594 (100 %)	0 diff (100 %id)
BP353060		.i	554 to 1130	1 to 577				577/583 (98 %)	1 diff (99.9 %id)
DA516049	brain	.j	1 to 540	2 to 542		tiling clone, capped		541/541 (100 %)	3 diff (99.5 %id)
CF129133	Chondrosarcoma Lung Metastasis cell lines, lung	.j	385 to 949	1 to 565				565/565 (100 %)	0 diff (100 %id)
TI_154190699		.j	385 to 956	51 to 622		tiling clone,		572/1018 (56 %)	3 diff (99.8 %id)
BF957833	nervous_normal	.j	689 to 1032	1 to 347		tiling clone,		347/351 (98 %)	25 diff (92.9 %id)
BM995919	lung, Metastatic Chondrosarcoma	.k	1 to 566	584 to 19	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	566/566 (100 %)	0 diff (100 %id)
DB512158	testis	.l	1 to 426	2 to 427	exact	tiling clone,	Submitted on the opposite strand	427/427 (100 %)	1 diff (99.8 %id)
BX437444	thymus	.m	1 to 864	8 to 870		tiling clone,		863/870 (99 %)	6 diff (99.4 %id)
DW410624	Liver	.m	371 to 687	333 to 17		tiling clone,		317/333 (95 %)	0 diff (100 %id)
BX437443	thymus	.m	1082 to 2019	937 to 1		tiling clone,		937/937 (100 %)	2 diff (99.8 %id)
CN390146	embryonic stem cells, cell lines H1, H7, andH9	.n	1 to 652	1 to 653	C101S	tiling clone,		653/653 (100 %)	8 diff (98.8 %id)
R63774	placenta	.o	1 to 323	10 to 332	Y2D H12T K13S S14R T15L ...	tiling clone, fully sequenced,		323/332 (97 %)	10 diff (97.0 %id)
R64546	placenta	.o	6 to 408	1 to 408		tiling clone,		408/422 (96 %)	23 diff (94.6 %id)
BQ025785	placenta	.o	151 to 619	485 to 17		tiling clone, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	469/469 (100 %)	0 diff (100 %id)
BQ026230	placenta	.o	269 to 619	366 to 16		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	351/351 (100 %)	1 diff (99.8 %id)
R63725	placenta	.o	297 to 617	320 to 1		fully sequenced,		320/320 (100 %)	5 diff (98.5 %id)
DB461448	testis	.p	1 to 495	1 to 495	exact	tiling clone,		495/495 (100 %)	0 diff (100 %id)
BC047335	Cervix, carcinoma	.q	1 to 649	1 to 649	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	649/649 (100 %)	0 diff (100 %id)
BI253724	cervical carcinoma cell line, cervix	.q	3 to 672	1 to 672		available from MGC,		672/687 (97 %)	19 diff (97.3 %id)
DB485279	hypothalamus	.q	230 to 691	1 to 462				462/462 (100 %)	6 diff (98.8 %id)
BU568417	testis	.q	238 to 649	1 to 412				412/755 (54 %)	4 diff (99.5 %id)
AV745053	cord Blood	.q	240 to 518	1 to 272				277/281 (98 %)	9 diff (96.8 %id)
AJ712966	bone marrow	.q	241 to 660	11 to 432				422/432 (97 %)	7 diff (98.4 %id)
AI264058	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q	247 to 669	425 to 3				423/425 (99 %)	1 diff (99.8 %id)
DW419069	Liver	.q	250 to 648	10 to 409				400/409 (97 %)	7 diff (98.3 %id)
TI_158432884		.q	251 to 680	525 to 96		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	430/844 (50 %)	2 diff (99.8 %id)
CF528661	placenta	.q	251 to 680	449 to 20		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	430/436 (98 %)	2 diff (99.6 %id)
AI807342	pooled	.q	253 to 672	423 to 4				420/423 (99 %)	0 diff (100 %id)
AA400692		.q	255 to 639	1 to 384				384/384 (100 %)	1 diff (99.8 %id)
AA626161		.q	255 to 672	420 to 4				417/420 (99 %)	1 diff (99.8 %id)
BQ185837	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.q	267 to 673	1 to 407		fully sequenced, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	407/407 (100 %)	1 diff (99.8 %id)
AI246365	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q	268 to 671	404 to 1				404/404 (100 %)	0 diff (100 %id)
AI124080	heart	.q	277 to 671	395 to 1				395/395 (100 %)	1 diff (99.8 %id)
BC063510	Eye, retinoblastoma	.q	288 to 1463	1 to 1174		tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	1174/1174 (100 %)	2 diff (99.9 %id)
CA314374	Human Lung Epithelial cells, lung	.q	298 to 665	368 to 1				368/377 (97 %)	3 diff (99.3 %id)
AA906202	pooled	.q	302 to 669	374 to 7				368/387 (95 %)	2 diff (99.5 %id)
BE781734	eye, retinoblastoma	.q	309 to 1025	1 to 713		available from MGC,		713/926 (76 %)	69 diff (92.6 %id)
AA969154	pooled	.q	331 to 669	339 to 1				339/339 (100 %)	1 diff (99.8 %id)
AA976773	pooled germ cell tumors	.q	338 to 669	346 to 15		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	332/332 (100 %)	1 diff (99.7 %id)
AA894926	Kidney	.q	346 to 669	331 to 8				324/331 (97 %)	0 diff (100 %id)
AJ346049	pectoral muscle (after mastectomy)	.q	349 to 666	1 to 318		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	318/322 (98 %)	2 diff (99.4 %id)
AW087479	pooled	.q	354 to 669	323 to 8				316/323 (97 %)	0 diff (100 %id)
AW004773	colon	.q	369 to 669	316 to 16		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	301/303 (99 %)	0 diff (100 %id)
BQ184154	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.q	369 to 673	321 to 17		fully sequenced, AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	305/305 (100 %)	1 diff (99.7 %id)
BQ011379	placenta	.q	379 to 680	322 to 21		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	302/304 (99 %)	0 diff (100 %id)
CA311140	Human Lung Epithelial cells, lung	.q	421 to 665	245 to 1				245/245 (100 %)	3 diff (98.8 %id)
BU589224	mixed (pool of 40 RNAs)	.q	436 to 673	1 to 238		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	238/240 (99 %)	4 diff (98.4 %id)
FN091387	breast carcinoma	.q	471 to 566	1 to 97				97/98 (98 %)	2 diff (98.0 %id)
FN091303	breast carcinoma	.q	477 to 565	90 to 1			Submitted on the opposite strand	90/91 (98 %)	1 diff (99.0 %id)
BQ012280	placenta	.q	522 to 682	176 to 16		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	161/161 (100 %)	1 diff (99.4 %id)
DB554303	hypothalamus	.q	978 to 1426	1 to 449			Submitted on the opposite strand	449/449 (100 %)	8 diff (98.3 %id)
BX099937	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.q	1011 to 1426	429 to 15		AAA	Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base)	415/415 (100 %)	1 diff (99.8 %id)
AI368527	anaplastic oligodendroglioma, brain	.q	1018 to 1429	417 to 7				411/473 (86 %)	0 diff (100 %id)
H67176	nose, olfactory epithelium	.q	1102 to 1410	1 to 309		fully sequenced,		309/309 (100 %)	4 diff (98.8 %id)
AI560533	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.q	1144 to 1428	284 to 1				284/284 (100 %)	1 diff (99.7 %id)
AI692342	carcinoid, lung	.q	1157 to 1429	275 to 4				272/275 (98 %)	0 diff (100 %id)
H67855	nose, olfactory epithelium	.q	1160 to 1401	251 to 1		fully sequenced,		251/251 (100 %)	5 diff (98.1 %id)
H67761	liver and spleen	.r	1 to 464	1 to 475	exact	tiling clone,		475/490 (96 %)	14 diff (97.2 %id)
BF223264	pooled germ cell tumors	.r	331 to 715	482 to 98		tiling clone,		385/482 (79 %)	0 diff (100 %id)
H67762	liver and spleen	.r	925 to 1271	366 to 6		tiling clone,		361/430 (83 %)	18 diff (95.9 %id)
BX365108	Placenta Cot 25-normalized	.s	1 to 736	15 to 748	C19X	tiling clone,		734/748 (98 %)	6 diff (99.2 %id)
BI560707	testis	.s	137 to 657	1 to 522	P24A T34S			522/655 (79 %)	10 diff (98.5 %id)
TI_44349697		.s	142 to 657	87 to 603	P24A T34S			517/736 (70 %)	12 diff (98.4 %id)
BG722300	testis	.t	1 to 618	1 to 624	P24S	tiling clone,		622/624 (99 %)	12 diff (98.1 %id)
DB447003	testis	.u	1 to 424	1 to 424	exact	tiling clone,		424/424 (100 %)	3 diff (99.3 %id)
DA099274	cerebellum	.u	60 to 612	2 to 554	exact	tiling clone, capped		553/553 (100 %)	0 diff (100 %id)
DB462393	testis	.va	1 to 472	1 to 472	exact	tiling clone,		472/472 (100 %)	0 diff (100 %id)
T61496	ovary	.vb-u	1 to 135	134 to 1	C35X V36S N37T P38L T39X ...	tiling clone,		134/134 (100 %)	1 diff (99.3 %id)
AU157496	placenta	Gene DHX30, variant not shown					Suspected internal deletion, this clone was ignored
AU138167	placenta	Gene DHX30, variant not shown				capped	Suspected internal deletion, this clone was ignored

288 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.